Study reveals possible interventions for cancer, obesity
January 11th, 2011 - 6:00 pm ICT by ANIWashington, Jan 11 (ANI): A new research may have opened doors to significant implications in the treatment and intervention of cancer and obesity.
Dr. Jan-Ake Gustafsson at the University of Houston (UH) reported the most recent results pertaining to the function of a nuclear receptor called estrogen receptor beta, or Erbeta.
The group found that this regulatory molecule prevents epithelial-to-mesenchymal transition, or EMT, in the prostate gland.
EMT is believed to have an essential role in prostate tumor development. ERbeta also has a growth-suppressive effect in colon cancer cells.
The findings suggest that this molecule is potentially an interesting pharmaceutical target in many diseases, including cancer.
Another research by Gustafsson and his team shows that two specific nuclear receptors - LXRalfa and LXRbeta - act in such a way as to indicate they have a crucial role in regulating energy homeostasis, which is important to maintain the stability of normal biological states during adjustments to environmental changes.
Gustafsson believes that these molecules should be considered as targets in pharmaceutical intervention against obesity.
The articles are titled “Estrogen Signaling via Estrogen Receptor Beta” and “Both liver-X receptor (LXR) isoforms control energy expenditure by regulating Brown Adipose Tissue activity,” respectively.
The review is published in the Journal of Biological Chemistry. (ANI)
- Female sex hormone regulates weight - Oct 20, 2011
- Key to get estrogen's benefits without cancer risk found - Jun 24, 2010
- Estrogen helps women pile on pounds - Oct 06, 2011
- New way to halt expansion of breast cancer stem cells discovered - Nov 24, 2010
- Obesity begins in brain, say US researchers - Feb 04, 2012
- Evidence of unusual drug-resistant breast tumours found - Oct 09, 2010
- Why PSA levels reflect prostate cancer progression - Jan 14, 2011
- Australian scientists identify new way to treat prostate cancer - Feb 26, 2010
- Our body clocks determine how much fat we burn - Nov 16, 2010
- Conventional theory of modern drug design challenged - Oct 11, 2010
- Trio of drugs may help fight 'triple negative' breast cancer - Dec 11, 2010
- Scientists uncover 'dark side' of beta-carotene - May 03, 2012
- New fluorescent biosensor to aid drug development - Jul 30, 2010
- Compound found in liquorice root could treat brain diseases - Nov 14, 2010
- Beer may prevent prostate cancer - Dec 09, 2009
Tags: ake, brown adipose tissue, colon cancer, colon cancer cells, control energy, dr jan, emt, energy expenditure, energy homeostasis, estrogen receptor, gustafsson, journal of biological chemistry, nuclear receptor, nuclear receptors, pharmaceutical intervention, prostate gland, receptor beta, target, tumor development, university of houston